Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication.

Roseguini BT, Hirai DM, Alencar MC, Ramos RP, Silva BM, Wolosker N, Neder JA, Nery LE.

Am J Physiol Regul Integr Comp Physiol. 2014 Aug 15;307(4):R396-404. doi: 10.1152/ajpregu.00183.2014. Epub 2014 Jun 18.

PMID:
24944249
2.

Dyspnea in Eisenmenger syndrome and its amelioration by sildenafil: role of J receptors.

Anand A, Srivastava N, Barwad P, Ramakrishnan S, Roy A, Bhargava B.

Int J Cardiol. 2014 Jul 1;174(3):574-8. doi: 10.1016/j.ijcard.2014.04.131. Epub 2014 Apr 21.

PMID:
24820738
3.

Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice.

Weissmann N, Peters DM, Klöpping C, Krüger K, Pilat C, Katta S, Seimetz M, Ghofrani HA, Schermuly RT, Witzenrath M, Seeger W, Grimminger F, Mooren FC.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 1;306(11):L986-95. doi: 10.1152/ajplung.00275.2013. Epub 2014 Apr 4.

PMID:
24705723
4.

Predictors of sildenafil effects on exercise capacity in adolescents and adults with Fontan circulation.

Hager A, Weber R, Müller J, Hess J.

Clin Res Cardiol. 2014 Aug;103(8):641-6. doi: 10.1007/s00392-014-0694-2. Epub 2014 Mar 18.

PMID:
24639042
5.

Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.

Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM.

Circ Heart Fail. 2014 Jan;7(1):123-30. doi: 10.1161/CIRCHEARTFAILURE.113.000568. Epub 2013 Oct 25.

6.

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E; RELAX Trial.

JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.

7.

Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men.

Attinà TM, Drummond ID, Malatino LS, Maxwell SR, Webb DJ.

Am J Hypertens. 2013 Mar;26(3):342-50. doi: 10.1093/ajh/hps057. Epub 2013 Jan 7.

PMID:
23382484
8.

Sildenafil improves microvascular O2 delivery-to-utilization matching and accelerates exercise O2 uptake kinetics in chronic heart failure.

Sperandio PA, Oliveira MF, Rodrigues MK, Berton DC, Treptow E, Nery LE, Almeida DR, Neder JA.

Am J Physiol Heart Circ Physiol. 2012 Dec 15;303(12):H1474-80. doi: 10.1152/ajpheart.00435.2012. Epub 2012 Sep 28.

9.

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.

Redfield MM, Borlaug BA, Lewis GD, Mohammed SF, Semigran MJ, Lewinter MM, Deswal A, Hernandez AF, Lee KL, Braunwald E; Heart Failure Clinical Research Network.

Circ Heart Fail. 2012 Sep 1;5(5):653-9. No abstract available.

10.

Lack of tight association between quality of life and exercise capacity in pulmonary arterial hypertension.

Cícero C, Franchi SM, Barreto AC, Lopes AA.

Arq Bras Cardiol. 2012 Oct;99(4):876-85. Epub 2012 Aug 30. English, Portuguese.

11.

Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.

Williams R, Houser L, Miner P, Aboulhosn J.

Congenit Heart Dis. 2012 Jan-Feb;7(1):12-5. doi: 10.1111/j.1747-0803.2011.00606.x. Epub 2011 Dec 21.

PMID:
22188797
12.

Sildenafil has little influence on cardiovascular hemodynamics or 6-km time trial performance in trained men and women at simulated high altitude.

Jacobs KA, Kressler J, Stoutenberg M, Roos BA, Friedlander AL.

High Alt Med Biol. 2011 Fall;12(3):215-22. doi: 10.1089/ham.2011.0011.

PMID:
21962064
13.

Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.

Zhang ZN, Jiang X, Zhang R, Li XL, Wu BX, Zhao QH, Wang Y, Dai LZ, Pan L, Gomberg-Maitland M, Jing ZC.

Heart. 2011 Nov;97(22):1876-81. doi: 10.1136/heartjnl-2011-300344. Epub 2011 Sep 21.

PMID:
21948962
14.

The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.

Zeng WJ, Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Gu Q, Zhao ZH, Li JJ, He JG; Sildenafil Therapy on Pulmonary Arterial Hypertension Associated With Different Types of Congenital Heart Disease Study Group.

Clin Cardiol. 2011 Aug;34(8):513-8. doi: 10.1002/clc.20917. Epub 2011 Jun 15.

PMID:
21678455
15.

Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.

Yang-Ting S, Aboulhosn J, Sun XG, Child JS, Sietsema KE.

Congenit Heart Dis. 2011 Mar-Apr;6(2):139-46. doi: 10.1111/j.1747-0803.2011.00490.x. Epub 2011 Mar 21.

PMID:
21418531
16.

Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.

D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R.

Int J Cardiol. 2012 Mar 22;155(3):378-82. doi: 10.1016/j.ijcard.2010.10.051. Epub 2010 Nov 16.

PMID:
21081251
17.

Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension.

Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S.

J Cardiopulm Rehabil Prev. 2010 Sep-Oct;30(5):319-23. doi: 10.1097/HCR.0b013e3181d6f962.

PMID:
20410828
18.

Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.

Tay EL, Papaphylactou M, Diller GP, Alonso-Gonzalez R, Inuzuka R, Giannakoulas G, Harries C, Wort SJ, Swan L, Dimopoulos K, Gatzoulis MA.

Int J Cardiol. 2011 Jun 16;149(3):372-6. doi: 10.1016/j.ijcard.2010.02.020. Epub 2010 Mar 20.

PMID:
20304507
19.

Current pharmacological treatment of pulmonary arterial hypertension.

Steiropoulos P, Trakada G, Bouros D.

Curr Clin Pharmacol. 2008 Jan;3(1):11-9. Review.

PMID:
18690874
20.

[Pulmonary arterial hypertension in women].

Sanchez O, Marié E, Lerolle U, Wermert D, Israël-Biet D, Meyer G.

Rev Mal Respir. 2008 Apr;25(4):451-60. Review. French.

PMID:
18536629
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk